© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
May 21, 2021
Individuals with opioid misuse disorders may be experiencing decreased access to naloxone during the COVID-19 pandemic.
April 27, 2021
A study presented at the American Academy of Neurology’s 73rd Annual Meeting aimed to identify predictors of acute treatment optimization in individuals with migraine
April 23, 2021
A session held at the HOPA Annual Meeting 2021 discussed best practices for optimizing opioid treatment in patients with cancer pain.
April 07, 2021
A 25-year study examines triptan use as an acute treatment strategy for migraines in a Danish population.
March 17, 2021
Pharmacists can counsel on prescription and OTC options, as well as nonpharmacologic measures.
March 12, 2021
Keynote speaker Dan Schneider, from the Netflix documentary “The Pharmacist,” discusses his story and mission to end the opioid epidemic.
March 04, 2021
Americans in underserved communities face barriers to opioid use disorder treatment.
February 17, 2021
In addition to reducing the frequency of migraine days, galcanezumab may also potentially decrease disabling non-pain symptoms of migraine on days when migraine is present.
February 10, 2021
The relatively new biologic therapies for migraine demonstrated low immunogenicity rates and rare adverse events.
January 22, 2021
Patients reported more frequent and severe migraines, along with overuse of analgesics.